LendingTree Shares Finish Week Up; Traders Set for Tuesday Reopen

May 23, 2026
LendingTree Shares Finish Week Up; Traders Set for Tuesday Reopen

New York, May 23, 2026, 11:06 EDT

LendingTree Inc. shares managed to end the week with a slight gain ahead of the Memorial Day break, after selling pressure late last month. The stock finished Friday at $36.42, off 0.46% for the day but about 1.9% higher than last Friday’s $35.73 close.

No trades scheduled until Tuesday. Nasdaq’s U.S. equity and options desks are closed Monday, May 25, for Memorial Day, making Friday’s session the last print before the short week.

Dow ended Friday at a record and the S&P 500 has now put up eight weekly wins in a row. That’s more than holding up. James St. Aubin, chief investment officer at Ocean Park Asset Management, told Reuters earnings and economic numbers have made “the picture look really solid.” Reuters

LendingTree isn’t as straightforward. The fintech depends on how much people want to look for loans and insurance, and its mortgage business moves with interest rates. Freddie Mac said the average 30-year fixed mortgage rate was 6.51% on May 21, up from 6.36% the previous week. The 15-year rate hit 5.85%.

LendingTree’s Q1 report gave a boost to bulls. The company logged $327.3 million in revenue for the first quarter, up 37% year over year. Insurance revenue climbed 51% to $221.9 million. LendingTree also raised its 2026 revenue outlook to $1.30 billion to $1.35 billion and sees Q2 adjusted EBITDA at $38 million to $40 million.

Management flagged some trouble spots. On the April earnings call, CEO Scott Peyree said weak consumer-loan demand was tied more to “consumer shopping behavior” than to credit access. CFO Jason Bengel told analysts the forecast bakes in “very, very muted seasonality” for consumer. Peyree said demand for home-loan products was at “historically low levels” with rates now higher than a few years back. The Motley Fool

LendingTree ended the week a bit higher, but moves across the online personal-finance space were uneven. NerdWallet added around 2% on Friday. Upstart lost almost 1%. Rocket Companies ticked down. That left LendingTree’s modest gain as more of a one-off than anything broad in the sector.

Macro data steps back in this week. The personal consumption expenditures price index, the Fed’s favored inflation metric, lands Thursday, Reuters said. Fresh figures on first-quarter growth and consumer confidence are also on the schedule. “The macro environment is starting to take more center stage,” said Anthony Saglimbene, chief market strategist at Ameriprise, as investors shift focus after earnings season. Reuters

But the risk is the macro backdrop. LendingTree’s latest quarterly filing points out that interest-rate moves could hit future marketplace revenue, and consumers can skip its site for direct offers from lenders or other online players. Hotter inflation, higher Treasury yields, or partners pulling back on credit could shrink the recent weekly gain.

LendingTree shares finish higher before the break, but didn’t break out. Investors will have to wait for Tuesday’s open to see if they back the insurance-driven growth or start pricing in the slower pieces of the company, which are still exposed to high rates and weak loan demand.

Stock Market Today

  • Australia Aspirin Market 2026-2035: Growth in Low-Dose Cardiovascular Segment amid Import Dependency
    May 23, 2026, 11:25 AM EDT. The Australia aspirin market is evolving, with low-dose (81 mg) formulations for cardiovascular prevention driving volume growth to 40-45% of unit sales by 2026. Private-label aspirin captures 25-30% of retail volume, pressuring branded producers amid a 50-60% price gap. The market depends on imports for over 90% of acetylsalicylic acid active pharmaceutical ingredient (API), mainly from China and India, exposing it to supply and cost volatility with input prices up 12-18% in 18 months. Aging demographics boost demand for prophylactic aspirin at 3-5% annual growth, outpacing traditional pain relief. Consumer trends favor coated and combination tablets now 20% of revenues. Online sales channels are expanding, making up 12-15% of volume. Challenges include regulatory costs, API price swings, stockouts, and retail consolidation squeezing supplier margins and innovation.